<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Stang A</submitter><funding>Intramural NIH HHS</funding><funding>German Cancer Aid (Deutsche Krebshilfe)</funding><pagination>492-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4024392</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(4)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The aim of this study was to provide detailed age-specific (5-year age groups) and histology-specific (histologic subtypes of seminoma and nonseminoma) relative survival estimates of testicular germ cell cancer patients in Germany and the United States (U.S.) for the years 2002-2006 and to compare these estimates between countries.&lt;h4>Methods&lt;/h4>We pooled data from 11 cancer registries of Germany and used data from the U.S. (SEER-13 database) including 11,508 and 10,774 newly diagnosed cases (1997-2006) in Germany and the U.S., respectively. We estimated 5-year relative survival (5-year-RS) by histology and age based on period analysis.&lt;h4>Results&lt;/h4>5-year-RS for testicular germ cell tumors was 96.7% and 96.3% in Germany and the U.S., respectively. 5-Year-RS for spe</pubmed_abstract><journal>Cancer epidemiology</journal><pubmed_title>Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.</pubmed_title><pmcid>PMC4024392</pmcid><funding_grant_id>108257</funding_grant_id><funding_grant_id>Z99 CA999999</funding_grant_id><pubmed_authors>Kieschke J</pubmed_authors><pubmed_authors>Eberle A</pubmed_authors><pubmed_authors>Kajuter H</pubmed_authors><pubmed_authors>GEKID Cancer Survival Working Group</pubmed_authors><pubmed_authors>Mattauch V</pubmed_authors><pubmed_authors>Geiss K</pubmed_authors><pubmed_authors>Stabenow R</pubmed_authors><pubmed_authors>Meyer M</pubmed_authors><pubmed_authors>Luttmann S</pubmed_authors><pubmed_authors>Holleczek B</pubmed_authors><pubmed_authors>Hentschel S</pubmed_authors><pubmed_authors>Kraywinkel K</pubmed_authors><pubmed_authors>Gondos A</pubmed_authors><pubmed_authors>Sirri E</pubmed_authors><pubmed_authors>Brenner H</pubmed_authors><pubmed_authors>Emrich K</pubmed_authors><pubmed_authors>Rusner C</pubmed_authors><pubmed_authors>Stang A</pubmed_authors><pubmed_authors>Trabert B</pubmed_authors><pubmed_authors>Katalinic A</pubmed_authors><pubmed_authors>Jansen L</pubmed_authors><pubmed_authors>Nennecke A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.</name><description>&lt;h4>Introduction&lt;/h4>The aim of this study was to provide detailed age-specific (5-year age groups) and histology-specific (histologic subtypes of seminoma and nonseminoma) relative survival estimates of testicular germ cell cancer patients in Germany and the United States (U.S.) for the years 2002-2006 and to compare these estimates between countries.&lt;h4>Methods&lt;/h4>We pooled data from 11 cancer registries of Germany and used data from the U.S. (SEER-13 database) including 11,508 and 10,774 newly diagnosed cases (1997-2006) in Germany and the U.S., respectively. We estimated 5-year relative survival (5-year-RS) by histology and age based on period analysis.&lt;h4>Results&lt;/h4>5-year-RS for testicular germ cell tumors was 96.7% and 96.3% in Germany and the U.S., respectively. 5-Year-RS for spe</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Aug</publication><modification>2025-04-05T13:37:20.641Z</modification><creation>2019-03-27T01:28:25Z</creation></dates><accession>S-EPMC4024392</accession><cross_references><pubmed>23623488</pubmed><doi>10.1016/j.canep.2013.03.017</doi></cross_references></HashMap>